Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
MDGL
#807
Madrigal Pharmaceuticals, Inc. Common Stock
518.580
0
USD
-1.22%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.22%
Changement Mensuel
+16.05%
Evolution sur 6 mois
+22.42%
Changement Annuel
+22.42%
Clôture Précédente
524.990
0
Open
518.580
0
Bid
Ask
Low
518.580
0
High
518.580
0
Volume
64
Marchés
Actions des Marchés US
Soins de Santé
MDGL
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
22.08 M
22.2 M
22.29 M
22.71 M
22.94 M
—
Valuation ratios
Enterprise value
6.83 B
7.29 B
6.68 B
10.46 B
13.5 B
37.93 B
Price to earnings ratio
-14.09
-18.57
-23.94
-35.83
-45.32
-123.66
Price to sales ratio
36.44
22.67
12.87
13.72
13.63
62.89
Price to cash flow ratio
-14.41
-18.08
-21.41
-61.13
-68.92
-169.55
Price to book ratio
8.7
2.31
2.25
3.62
21.68
29.85
Enterprise value to EBITDA ratio
-13.75
-17.16
-21.59
-34.08
-45.24
-118.07
Profitability ratios
Return on assets %
-0.06
-0.07
-0.04
-0.08
-0.05
-0.25
Return on equity %
-0.08
-0.1
-0.06
-0.18
-0.1
-0.44
Return on invested capital %
-1 640.46
—
—
—
-974.02
—
Gross margin %
100
96.71
100
100
100
396.71
Operating margin %
-64.84
-57.79
-22.18
-39.68
-18.56
-138.21
EBITDA margin %
-61.16
-60.8
-22
-39.55
-18.44
-140.8
Net margin %
-57.51
-53.36
-19.87
-39.75
-18.24
-131.22
Liquidity ratios
Quick ratio
5.9
5.58
4.78
3.26
3.77
17.4
Current ratio
6.1
5.91
5.11
3.44
4.01
18.47
Inventory turnover
—
0.1
—
—
—
—
Asset turnover
0.1
0.13
0.21
0.24
0.24
0.83
Solvency ratios
Debt to assets ratio
0.11
0.12
0.12
0.25
0.27
0.75
Debt to equity ratio
0.16
0.17
0.17
0.54
0.56
1.44
Long term debt to total assets ratio
0.11
0.12
0.12
0.25
0.27
0.75
Long term debt to total equity ratio
0.16
0.17
0.17
0.54
0.56
1.44
Per share metrics
Operating cash flow per share
-4.91
-4.02
-2.12
3.55
-5.95
-8.54
EBIT per share
-2.99
-3.79
-2.13
-5.07
-2.66
-13.65
EBITDA per share
-2.97
-3.78
-2.11
-5.05
-2.64
-13.58
Total debt per share
5.53
5.34
5.33
15.11
15.15
40.93
Cash per share
43.78
38.39
36.12
49.58
43.84
167.93
Net current asset value per share
48.56
44.72
45.18
59.9
55.53
205.33
Tangible book value per share
35.24
31.96
31.14
27.5
26.54
117.13
Working capital per share
40.6
37.15
36.33
42.49
41.7
157.67
Book value per share
35.46
32.17
31.34
27.83
26.86
118.21
Nouvelles
Wolfe Research réitère sa note Peerperform sur l’action Madrigal
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
ALT Pemvidutide Explained: What Makes It Different in MASH
Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Le directeur financier de Madrigal Pharmaceuticals vend pour 854.000$
Madrigal Pharmaceuticals EVP Dier sells $854k in stock
Le PDG de Madrigal Pharmaceuticals Sibold vend pour 718.000$ d’actions
Madrigal Pharmaceuticals CEO Sibold sells $718k in shares